Zeria Pharmaceutical Co., Ltd. (TYO:4559)

Zeria Pharmaceutical Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	27,706	27,760	23,592	20,323	16,219	11,704
Cash & Short-Term Investments	27,706	27,760	23,592	20,323	16,219	11,704
Cash Growth	38.68%	17.67%	16.09%	25.30%	38.58%	19.48%
Receivables	25,792	30,790	26,611	21,080	17,419	16,153
Inventory	22,528	20,896	16,433	14,489	12,764	11,950
Other Current Assets	3,750	3,200	2,893	1,917	1,801	1,856
Total Current Assets	79,776	82,646	69,529	57,809	48,203	41,663
Property, Plant & Equipment	27,387	27,599	26,641	26,517	24,591	23,139
Long-Term Investments	9,505	29,785	22,541	22,957	20,172	18,165
Goodwill	2,837	3,027	3,621	4,262	5,299	5,830
Other Intangible Assets	35,585	36,554	36,740	38,877	36,631	35,376
Long-Term Deferred Tax Assets	-	84	97	110	136	108
Other Long-Term Assets	19,595	2	2	1	2	1
Total Assets	174,685	179,697	159,171	150,533	135,034	124,282

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	5,734	4,895	3,971	3,273	1,996	2,049
Accrued Expenses	1,685	1,778	1,623	1,584	1,554	1,530
Short-Term Debt	31,278	33,834	34,298	38,283	34,890	33,842
Current Income Taxes Payable	3,006	4,827	3,773	1,967	749	458
Other Current Liabilities	9,788	10,374	10,784	9,411	7,969	6,314
Total Current Liabilities	51,492	55,708	54,449	54,518	47,158	44,193
Long-Term Debt	5,196	5,269	6,865	7,943	14,541	18,385
Pension & Post-Retirement Benefits	203.72	201	224	458	234	1,073
Long-Term Deferred Tax Liabilities	-	8,586	6,496	6,447	5,190	3,905
Other Long-Term Liabilities	9,522	1,329	1,341	1,339	2,232	1,635
Total Liabilities	66,413	71,093	69,375	70,705	69,355	69,191

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	6,593	6,593	6,593	6,593	6,593	6,593
Additional Paid-In Capital	5,621	5,620	11,685	11,685	11,685	11,685
Retained Earnings	73,310	73,545	67,207	59,254	53,462	48,860
Treasury Stock	-12,205	-12,204	-18,266	-18,265	-18,264	-17,593
Comprehensive Income & Other	34,720	34,842	22,320	20,355	11,973	5,349
Total Common Equity	108,039	108,396	89,539	79,622	65,449	54,894
Minority Interest	233.06	208	257	206	230	197
Shareholders' Equity	108,272	108,604	89,796	79,828	65,679	55,091
Total Liabilities & Equity	174,685	179,697	159,171	150,533	135,034	124,282

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	36,474	39,103	41,163	46,226	49,431	52,227
Net Cash (Debt)	-8,768	-11,343	-17,571	-25,903	-33,212	-40,523
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-198.91	-257.33	-398.62	-587.64	-751.86	-897.74
Filing Date Shares Outstanding	44.08	44.08	44.08	44.08	44.08	44.21
Total Common Shares Outstanding	44.08	44.08	44.08	44.08	44.08	44.41
Working Capital	28,284	26,938	15,080	3,291	1,045	-2,530
Book Value Per Share	2451.01	2459.11	2031.31	1806.31	1484.77	1236.08
Tangible Book Value	69,617	68,815	49,178	36,483	23,519	13,688
Tangible Book Value Per Share	1579.35	1561.16	1115.67	827.66	533.55	308.22

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 23, 2026

Data Sources Report a data error